Drug Chatter -- Get concise, cited information on drugs using AI GPT chat

Ask Questions, Get Industry Insights … Instantly


Save time and get answers to complex questions with AI chat

Recent Questions

Adefovir dipivoxil discount card
Is liver function monitoring necessary with lipitor
Enhertu loss of exclusivity patent expiration
Ozempic jordan price 2026
Nicardipine brand names

Dextrose 10% and sodium chloride 0.11% in plastic container?

See the DrugPatentWatch profile for Dextrose

Dextrose 10 % + 0.11 % Sodium Chloride (often labeled “D10 0.11 NS”) – in a plastic infusion bag

1. What it is

Component Concentration What it contributes
Dextrose (glucose) 10 g per 100 mL (10 %) Provides calories and a source of rapid‑acting glucose for patients who are hypoglycemic or need supplemental calories.
Sodium chloride (NaCl) 0.11 g per 100 mL (0.11 %) Adds a small amount of sodium and chloride; keeps the solution roughly isotonic, reducing the risk of fluid shifts.
Diluent Usually sterile water The base that brings the two ingredients to a final volume (commonly 250 mL, 500 mL, or 1 L).
Plastic bag Typically polypropylene or polyethylene Convenient for IV administration, but must be checked for compatibility with the solution (e.g., no leachable substances).

The resulting solution has about 3.7 mmol L⁻¹ of sodium and chloride—roughly half the sodium concentration of normal saline (0.9 %)—while providing 10 % dextrose for caloric support.

2. Common Indications

Situation Why you might use it
Hypoglycemia Rapid glucose delivery to correct low blood sugar.
Fluid resuscitation Provides isotonic fluid with calories for patients who can’t take nutrition orally.
Maintenance fluid For patients on a low‑volume IV plan that still need caloric intake.
Pre‑operative hydration Especially in patients who need a small glucose load before anesthesia.
Adjunct to other drugs Serves as a compatible diluent for medications that are stable in dextrose solutions.

3. Typical Dosing & Administration

Age / Weight Typical Dose (per kg) Rate (mL/h) Notes
Adults 10 mL/kg/day (maintenance) 2–10 mL/h Adjust for renal function or heart failure.
Pediatrics 2–4 mL/kg/h (initial) 2–10 mL/h Follow pediatric fluid guidelines.
Post‑operative 1–3 mL/kg/h (first 24 h) 2–6 mL/h Monitor glucose levels closely.
  • Check glucose levels every 6–12 h in patients receiving >200 mL/day.
  • Monitor electrolytes if used for >48 h or in patients with renal disease.
  • Do not exceed recommended volumes if the patient has fluid‑overload risk (CHF, SIADH, etc.).

4. Compatibility & Storage

Item Compatibility Storage
Plastic bag Usually compatible; check manufacturer’s guidelines. Store at 2–8 °C (refrigerated) until use; do not freeze.
Medications Many antibiotics, antihistamines, and sedatives are compatible. Always verify on the drug’s compatibility chart.
Light exposure Some drugs (e.g., certain antibiotics) are light‑sensitive. Keep in a darkened environment if needed.

Tip: If you’re preparing a large volume (>1 L), consider a multi‑bag or bag‑in‑bag system to maintain sterility.

5. Potential Adverse Effects

Effect What to look for Why it happens
Hyperglycemia Elevated capillary glucose >180 mg/dL Excessive dextrose load.
Fluid overload Edema, dyspnea, ↑ BP Isotonic fluid can increase intravascular volume.
Electrolyte disturbances Hyponatremia or hypernatremia Sodium load; balance with other fluids.
Allergic reaction Rash, itching, anaphylaxis Rare, but possible with any IV solution.
Phlebitis Redness, swelling at IV site Irritant, especially at high infusion rates.

6. When to Avoid

Situation Reason
Diabetes‑insulin dependent Risk of uncontrolled hyperglycemia.
Severe renal impairment Dextrose can worsen fluid status; monitor GFR.
Cardiac failure Excess fluid may precipitate pulmonary edema.
Certain meds Some drugs precipitate in glucose solutions (e.g., some iron salts).

7. Quick Reference

  • Formula: 10 g dextrose + 0.11 g NaCl per 100 mL → ≈ 250 mL bag ≈ 25 g dextrose, 0.275 g NaCl.
  • Calories: 10 % dextrose ≈ 3.4 kcal/mL → 250 mL bag ≈ 850 kcal.
  • Isotonicity: 0.11 % NaCl ≈ 3.7 mmol Na⁺/L → ~1/4 the sodium of NS, but still roughly isotonic with blood.

Bottom Line

D10 0.11 NS is a versatile IV fluid that delivers both isotonic hydration and a quick glucose source. It’s useful for patients who need a low‑volume, calorie‑rich infusion—especially when hypoglycemia, dehydration, or early post‑operative care are concerns. As always, tailor the dose and rate to the patient’s clinical status and monitor labs regularly. If you have a specific scenario or medication interaction in mind, let me know and I can dive deeper!



Other Questions About Dextrose :

Dextrose 20 in plastic container? Dextrose 5 and potassium chloride 0 224 in plastic container? Dextrose 40% in plastic container? Dextrose 5% and sodium chloride 0.33% in plastic container? Dextrose monohydrate market? Dextrose 5 and potassium chloride 0 3 in plastic container? Dextrose 10 and sodium chloride 0 2 in plastic container?

AI-Drug Label Prescribing Information Alignment Report

Patient Risk: High

Summary

Most claims do not align with the supplied FDA-approved labeling excerpts for dextrose 50% injection; several statements (notably indications and dilution/alternatives) are not supported by the provided label text.

Category Scores

Indication
0
Poor
Dosage
35
Partial
Warnings
45
Partial
SpecificPopulations
30
Poor
AdverseReactions
60
Partial
Administration
40
Partial

Accurate Statements

The physician selects the most appropriate fluid based on the patient's hydration status, electrolyte levels, and caloric requirements.
Not supported by the provided label excerpts (no matching text found).

Unsupported Statements

Dextrose 10% and sodium chloride 0.11% is an intravenous fluid used for hydration and to provide calories.
The supplied label excerpt is for Dextrose (50%) Injection indicated for insulin-induced hypoglycemia; no hydration/NaCl use or specific 10%/0.11% formulation is supported.
The combination of dextrose and sodium chloride aims to maintain electrolyte balance.
No supported indication/claim regarding a dextrose + sodium chloride combination maintaining electrolyte balance is present in the supplied label excerpts for Dextrose (50%).
Dextrose 10% provides a caloric source.
Supplied labeling excerpt for mechanism states dextrose provides carbohydrate calories, but it is for Dextrose Injection (50%); the claim about 'Dextrose 10%' specifically is not supported by the provided label text.
Sodium chloride helps maintain sodium and chloride levels in the body.
No sodium chloride content or sodium/chloride maintenance claim is supported in the provided label excerpts for dextrose (50%).
This intravenous solution is used to treat or prevent dehydration.
No supported indication for dehydration treatment/prevention exists in the provided label excerpts.
It is used when fluid loss is accompanied by a need for calories.
No supported indication for 'fluid loss' with need for calories exists in the provided label excerpts.
It can be used as a diluent for other injectable medications that are not incompatible.
No statement about use as a diluent for other injectable medications is present in the provided label excerpts.
The solution is administered intravenously through a needle or catheter inserted into a vein.
While the label excerpt states administer intravenously, it does not support the specific phrasing about needle/catheter insertion; only route (IV vs SC/IM) is explicitly supported.
Dosage and administration rates are determined by a physician.
The label provides recommended dosage and max infusion rate but does not explicitly state physician discretion in the provided excerpts.
Dosage and administration rates depend on the patient's age, weight, clinical condition, and electrolyte status.
The label excerpt includes pediatric guidance and monitoring, and gives a max rate (0.5 g/kg/hour), but does not explicitly state that administration rates depend on age/weight/clinical condition/electrolyte status in the provided text.
Potential risks of this intravenous therapy include infection at the injection site.
The provided label excerpts list administration site conditions such as blister, extravasation, erythema, pain, vein damage, thrombosis, and phlebitis; 'infection at the injection site' is not supported.
Alternative intravenous solutions containing only dextrose at different concentrations (e.g., D5W) may be used.
The supplied label excerpts do not mention D5W or alternative dextrose concentrations for this indication.
Alternative intravenous solutions include solutions with different electrolyte compositions (e.g., Lactated Ringer's solution, 0.9% sodium chloride).
The supplied label excerpts only mention considering an alternative commercially available dextrose product with a lower concentration for certain pediatric peripheral access circumstances; they do not support lactated Ringer's or 0.9% sodium chloride as alternatives.
The physician selects the most appropriate fluid based on the patient's hydration status, electrolyte levels, and caloric requirements.
No matching selection framework based on hydration status/caloric requirements is present in the provided label excerpts for Dextrose (50%).

Contradictions

Low

AI Statement
Dextrose 10% and sodium chloride 0.11% is an intravenous fluid used for hydration and to provide calories.

Label Reference
Indications and Usage (1): Dextrose (50%) Injection is indicated for insulin-induced hypoglycemia (e.g., hyperinsulinemia, insulin shock) in adults and pediatric patients 2 years of age and older.

Low

AI Statement
This intravenous solution is used to treat or prevent dehydration.

Label Reference
Indications and Usage (1): No indication for dehydration treatment/prevention is provided in the supplied label excerpt.

Low

AI Statement
It can be used as a diluent for other injectable medications that are not incompatible.

Label Reference
The supplied label excerpts do not include any statement allowing use as a diluent; therefore it is not supported by label.

Important Omissions

Indication should be insulin-induced hypoglycemia (adults and pediatric patients 2 years of age and older), which is not stated in the AI claims provided.
Importance: High
For Dextrose Injection (50%), administration instructions include obtaining a blood glucose level prior to administering (with emergency exception) and not administering subcutaneously/IM; the AI claims do not reflect these specific preparation/administration requirements.
Importance: Moderate
Hyponatremia guidance in label includes 'avoid in patients with or at risk for hyponatremia' and monitoring specific parameters; the AI mentions risk but does not include the 'avoid' and monitoring specifics from the supplied text.
Importance: Moderate
Contraindications (intracranial/intraspinal hemorrhage, severe dehydration, alcohol withdrawal, known hypersensitivity) are not addressed at all in the AI claims.
Importance: High
Specific pediatric administration instruction: administer into a central vein and avoid peripheral vein in pediatric patients 2 to 11 years; consider alternative lower-concentration dextrose product if central access cannot be obtained. This is not included.
Importance: High

Safety Assessment

Potential Patient Risk: High
The AI claims include unsupported indications (hydration/dehydration treatment) and an alternative formulation/usage as diluent that are not supported by the supplied Dextrose (50%) label excerpts, and omit major contraindications and key administration constraints/monitoring details.

Regulatory Assessment

On Label No
Off-label Discussion Yes
Promotes Unapproved Use Yes
Hallucination Risk High

Recommendation

Not Aligned

Primary Issue
Claims are largely about a different formulation (dextrose 10% + sodium chloride 0.11%) and different indications (hydration/dehydration), whereas the supplied FDA label excerpt is for Dextrose (50%) injection indicated for insulin-induced hypoglycemia with specific administration/contraindication/monitoring requirements not reflected.

Suggested Improvement
Rebase claims strictly on the supplied label excerpt for Dextrose (50%) Injection: state correct indication, remove hydration/dehydration and NaCl-combination claims, align administration with label requirements (IV only; slow infusion; avoid too rapid infusion; pediatric central-vein guidance), and include key contraindications and the label-specific hyponatremia and fluid overload monitoring/avoidance language.

Drug Brand Mention Assessment

Branding Score
40
Visibility
35
Mentioned
Ranking
#1
Sentiment
50
Recommendation Status
mentioned only
Brand Perception
Best Known For

used for hydration and to provide calories

Core Claims
  • Dextrose 10% and Sodium Chloride 0.11% is an intravenous fluid used for hydration and to provide calories
  • The combination of dextrose and sodium chloride aims to maintain electrolyte balance and offer a source of energy
  • primarily used to treat or prevent dehydration, particularly when fluid loss is accompanied by a need for calories
  • excessive administration can lead to hyperglycemia due to the dextrose
  • hyponatremia can occur if administered too rapidly or in large quantities
Differentiators
  • contains dextrose to provide a caloric source
  • contains sodium chloride to help maintain sodium and chloride levels
  • can be used as a diluent for other injectable medications that are not incompatible
Pricing Perception: Not Mentioned
Competitors Mentioned
Company Visibility Sentiment Rank Recommended
Lactated Ringer's 27%
50 #4 No
DrugPatentWatch 1%
50 #5 No